Research > ETFs > ETF / ETP Commentary > 

ETF Prime: Goldman's ETF Acquisitions & the Gambling Debate

Goldman Sachs ETF acquisitions and the blurring line between investing and gambling headlined this week’s ETF Prime. Host Nate Geraci welcomed Mike Akins, founding partner at ETF Action, followed by Paul Baiocchi, head of fund sales and strategy at SS&C ALPS Advisors.Key Takeaways: Goldman is acquiring Neos Investments for up to $2.25 billion, its second major ETF deal of 2026. Akins warns that sports betting ETFs give gambling vehicles a misleading regulatory stamp of approval. IDOG is up roughly 65% since the start of last year, compared to around 34% for the S&P 500. Akins opened with Goldman’s agreement to acquire Neos Investments for up to $2.25 billion. It marks Goldman’s second major ETF deal of the year, following its earlier acquisition of Innovator ETFs. Neos launched its first ETF just four years ago and has since grown to over $30 billion in assets. Akins noted the main integration hurdle will be securing proxy votes from Neos shareholders to approve the change of control required to complete the acquisition. Akins was also critical of Volatility Shares’ filing for National Hockey League futures contract ETFs, calling them gambling vehicles dressed up as investment products. He said placing speculative products inside regulated structures gives them an unwarranted “stamp of approval.” A Betterment survey found that 52% of Gen Z investors have pulled from investment accounts to fund sports betting. Akins added that the negative roll yield on these products will make the United States Oil Fund (USO B) look tame.International Dividends and Active Fixed IncomeBaiocchi introduced the ALPS International Sector Dividend Dogs ETF (IDOG B-), which targets the five highest-yielding stocks across the ten Global Industry Classification Standard sectors of the MSCI EAFE index. The fund holds those names in an equal-weighted portfolio of 50 stocks. Since the beginning of last year, IDOG is up roughly 65%, compared to around 34% for the S&P 500. See more: Value Stocks Drive IDOG Past Broader Market in July He also noted that U.S. equities outperformed international stocks for 16 consecutive years before last year. International valuations remain at steep discounts, and a weakening dollar provides a structural tailwind. Most advisors remain structurally underweight international despite targeting 10% to 15% allocations. Additionally, Baiocchi highlighted the ALPS Smith Core Plus Bond ETF (SMTH ). Gibson Smith, the former chief investment officer at Janus, manages the fund. It has gathered over $700 million in year-to-date inflows, focusing on quality and portfolio ballast rather than chasing credit risk or duration.Listen to the Latest Episode of ETF Prime:For more ETF Prime podcast episodes, visit our ETF Prime Content Hub. VettaFi LLC (“VettaFi”) is the index provider for IDOG, for which it receives an index licensing fee. However, IDOG is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of IDOG.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.